Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered

• Joel Hanhart,
• Sohee Jeon,
• Raimo Tuuminen

Affiliations

Joel Hanhart

Department of Ophthalmology, Shaare Zedek Medical Center Jerusalem Israel

Sohee Jeon

Vitreoretinal Service Keye Eye Center Seoul South Korea

Raimo Tuuminen

Department of Ophthalmology Kymenlaakso Central Hospital Kotka Finland